US · Healthcare

Pharmala Biotech Holdings Inc (MDXXF)

Biotechnology

Pharmala Biotech Holdings Inc (MDXXF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MDXXF

P/E ratio

25.00

Pharmala Biotech Holdings Inc (MDXXF) — FAQ

What is MDXXF's P/E ratio?

The price-to-earnings (P/E) ratio for Pharmala Biotech Holdings Inc (MDXXF) is 25.00 (data as of 2026-05-23).

Does Pharmala Biotech Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Pharmala Biotech Holdings Inc (MDXXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Pharmala Biotech Holdings Inc in?

Pharmala Biotech Holdings Inc (MDXXF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MDXXF listed on?

MDXXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)